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Abstract
Background
“Big data” is increasingly being used for orthopaedic research. However, the acute and
complex nature of orthopaedic trauma makes data collection and data analysis difficult.
This thesis presents three different clinical studies, which together illustrate how
databases may best be used to answer clinical questions in orthopaedic trauma.
Specifically the studies aim to show (1) how different databases capture trauma
populations, (2) how databases may be used for hypothesis discovery studies, and (3)
how databases may be used for hypothesis testing studies.
Study Questions
(1) How do populations of femoral shaft fracture patients differ in three commonly used
national databases, specifically in regards to age and preexisting comorbidities? (2) What
risk factors are associated with delayed surgery after elderly hip fractures in a national
cohort and subsequently an institutional cohort? (3) Does hospital resource utilization
differ between subpopulations of patients in Medicare Diagnosis Related Group 536
(fractures of the hip and pelvis), despite equal Medicare hospital reimbursement?
Methodology
(1) Patients with surgically managed femoral shaft fractures were identified in the
Nationwide Inpatient Sample (NIS), National Surgical Quality Improvement Program
(NSQIP) and National Trauma Data Bank (NTDB). The distributions of age and
Charleston Comorbidity Index were compared between populations. (2) A retrospective
cohort study was conducted of all elderly hip fracture patients receiving surgical
management from 2011-2012 in the NTDB and from 2009-2015 at a single academic

2

trauma center. Multivariate analysis was used to identify the independent effect of
various risk factors on surgical timing. (3) Patients with hip fractures, non-operative
pelvic fractures, acetabulum fractures, and operative pelvic fractures were identified in
the 2011 – 2012 NTDB. Total inpatient length of stay, intensive care unit (ICU) stay, and
ventilator time were compared across groups using multivariate analysis that controlled
for patient and hospital factors.
Results
(1) A predominantly older population with more preexisting comorbidities was found in
NSQIP (age = 71.5, CCI = 4.9), while a substantially younger population with fewer
preexisting comorbidities was fond in NTDB (age = 45.2, CCI = 2.1). Bimodal
distributions in the NIS population indicate a more mixed population (age = 56.9, CCI =
3.2). Differences in age were all statistically significant (p < 0.001). (2) In the national
cohort, mean time to surgery was 31.3 hours (standard deviation: 31.6 hours). The risk
factors with largest association with delays were total arthroplasty surgery (coefficient, in
hours [95% confidence interval]: 7.7 [6.1 – 9.3]) coagulopathy, including chronic
anticoagulation (7.1 [6.1 – 8.0]), and congestive heart failure (6.9 [6.0 – 7.9]). In the
institutional cohort, mean time to surgery was 32.4 hours (standard deviation: 29.0
hours). In this cohort, the only statistically significant risk factors associated with surgical
timing were total arthroplasty surgery (24.5 [13.7 – 35.4]), transfer from outside hospital
(22.1 [15.1 – 29.1]), warfarin anticoagulation (13.7 [8.5 – 18.8]), other anticoagulation
(10.5 [2.4 – 18.5]), and preoperative hematocrit < 35% (5.5 [2.0 – 9.0]). (3) After
controlling for patient and hospital factors, the difference in inpatient length of stay
compared to hip fracture patients was -0.2 days (95% C.I.: -0.4 to -0.1 days; P = 0.001)
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for non-operative pelvis fractures, 1.7 days (95% C.I.: 1.4 to 1.9 days; P < 0.001) for
acetabulum fractures, and 7.7 days (95% C.I.: 7.0 to 8.4 days; P < 0.001) for operative
pelvic fractures. Similar differences were also noted for IVU stay and ventilator time.
Conclusion
(1) While these three national databases have been commonly used for orthopaedic
trauma research, differences in the populations they contain are not always readily
apparent. Care must be taken to fully understand these populations before performing or
evaluating database research, as these differences clearly affect observed outcomes. (2)
Of all risk factors identified, access to arthroplasty and management of chronic
anticoagulation may be the most modifiable in order to reduce delayed hip fracture
surgeries. Physician call coverage and algorithms for more rapid reversal of
anticoagulation, namely warfarin anticoagulation, warrant further investigation.
(3) Because hospitals are reimbursed equally for these subgroups of Medicare DRG 536,
those centers that care for a greater proportion of more-complex pelvic trauma will
experience lower financial margins per trauma patient, limiting their potential for growth
and investment compared with competing institutions that may not routinely see highenergy trauma.
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Introduction to Thesis
The use of large national databases in orthopaedic research has grown
substantially over the last 10 years.1 While the randomized controlled trial (RCT)
remains the gold standard for answering clinical questions, RCTs are often unfeasible,
especially in orthopaedic settings. An adequately powered trial requires a large number of
patients, often from multiple centers, with the logistics of this making RCTs very costly.
The large Spine Patients Outcomes Research Trial (SPORT) was estimated to cost $30
million,1, 2 while the smaller Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST)
cost $7 million.1
In addition blinding to placebo or “sham surgery” treatments may be unethical in
many cases, while this blinding has also proven to be essential to avoid bias based on
patient expectations. For example Moseley et al found that after randomizing 180 patients
to arthroscopic knee debridement, lavage, or sham surgery that patient reported outcomes
were no different between groups.3 Furthermore, when surgical treatment is not blinded
there remains the potential for substantial cross over from placebo to treatment groups, as
was seen in the SPORT trial with conservatively managed patients eventually wanting
surgical treatment for non-resolving symptoms.4
As these issues make RCTs impractical in many cases, the observational cohort
study has come to be the standard for clinical research in orthopaedic surgery. Indeed, a
well-designed observational study, carefully controlling for potential sources of bias, may
provide a strong level of evidence, which approaches that of an RCT. For example in the
SPORT trial, while intention-to-treat data was found to be inconclusive due to high rates
of cross-over,4 a secondary observational study of the data based on per protocol analysis
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and carefully controlling for sources of bias, did demonstrate benefits with surgical
treatment of herniated lumbar discs.5
Large national databases provide a unique platform for observational clinical
studies providing large patient populations suitable for studying rare procedures,
populations, and outcomes that would otherwise be difficult to study by a single provider,
institution, or even group of institutions.1, 6 As data collection is done preemptively, these
studies can be completed at low cost, and with careful study design, several of the
inherent biases of retrospective studies can be controlled for. The lack of orthopaedicspecific data elements in many of the presently general surgery-focused national
databases does limit the ability to measure orthopaedic outcomes of interest, such as
functionality measures, and control for factors that influence orthopaedic outcomes, such
as implant use or fracture classification. Nevertheless, the wealth of data available in
these national datasets has already allowed several impactful studies to be completed.7-13
Clinical studies utilizing “big data” in orthopaedic surgery can be classified into
two broad categories: hypothesis-finding and hypothesis-testing studies. Hypothesisfinding studies leverage the large patient populations and numerous data elements
contains in databases to identify risk factors associated with surgical outcomes. For
example Basques et al. identified several risk factors for blood transfusion in over 4,000
patients undergoing primary posterior lumbar fusion, including a greater number of levels
fused, longer operative time, and preoperative anemia.14 This type of study opens the
door for further investigation of targeted interventions that may prevent blood
transfusions in this population. It also provides risk stratification information to providers
for both patient counseling and surgical planning purposes. In contrast, hypothesis-testing
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studies aim to answer a narrowly defined questions using statistical testing controlling for
other confounding factors. For example, Bohl et al determined that patients receiving
intramedullary implants for intertrochanteric hip fractures had a shorter postoperative
lengths of stay compared with those receiving extramedullary implants.7 This type of
study adds to the body of literature that may favor one method of treatment versus
another, impacting clinical standards of care. In orthopaedic surgery, both hypothesisfinding and hypothesis-testing studies have utility in answering clinical questions and
directing practice.
While many orthopaedic questions have been answered using “big data,” one
population that remains difficult to study are orthopaedic trauma populations. In the acute
trauma setting, careful data collection is often difficult when urgent test and interventions
are necessary. In addition there is considerable variability in injury patterns and
associated injuries among fracture patients, all of which may not be well captured in
databases but do still impact clinical management and patient outcomes. Nevertheless,
“big data” has already been used extensively to study orthopaedic trauma populations.
Therefore, it is important to identify effective methods for conducting clinical research on
orthopaedic fracture populations, using large national databases.
The current work aims to address this goal in three sections, each an individual
completed clinical study, either published or submitted for publication, illustrating a
different aspect of research design. In Section I, entitled “Do we really know our patient
population in database research: A comparison of the femoral shaft fracture patient
populations in three commonly used national databases,” the high-energy femoral shaft
fracture populations in three databases are compared. By doing this, the importance of
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selection of an appropriate database for studying high-energy trauma populations is
highlighted.
In Section II, entitled “Using a National Database and Subsequently an
Institutional Cohort to Identify Potentially Modifiable Risk Factors for Delayed Hip
Fracture Surgery: An example of using databases for hypothesis discovery,” an example
of a hypothesis-finding study is presented as risk factors for delayed surgery after elderly
hip fractures are analyzed. In addition, these risk factors are further explored using a local
institutional cohort of hip fracture patients to identify modifiable factors that may
expedite surgery after hip fractures locally. In this way the utility of hypothesis finding
for further investigative efforts is highlighted.
Finally in Section III, entitled “Variation in Resource Utilization for Hip and
Pelvic Fracture Patients, Despite Equal Medicare Reimbursement,” the specifically
defined hypothesis of whether subgroups of patients in Medicare Diagnosis Related
Group (DRG) 536 (fractures of the hip and pelvis) have different amounts of hospital
resource utilization, is tested. Larger health policy implications of the findings are then
discussed, illustrating the potential power of large well-powered databases studies for
identifying clinically significant trends. Together the aim of the current thesis is to
illustrate the utility of thoughtfully designed clinical research using “big data” to study
the complex population of fracture patients.
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Section I

Do we really know our patient population in database research: A comparison of
the femoral shaft fracture patient populations in three commonly used national
databases

Published as:

Samuel AM, Lukasiewicz AM, Webb ML, Bohl DD, Basques BA, Varthi AG, Leslie
MP, Grauer JN. "Do we really know our patient population in database research?: A
comparison of the femoral shaft fracture patient populations in three commonly used
national databases.” Bone Joint J. (Accepted Sept 2015, in press)
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Background
The use of national databases for clinical research has increased dramatically in
the field of orthopaedic surgery over the past 5 years (Figure 1). Examples of databases
currently being used in orthopaedic research include the Nationwide Inpatient Sample
(NIS),15, the American College of Surgeons National Surgical Quality Improvement
Program database (NSQIP),16 and the American College of Surgeons National Trauma
Data Bank Research Data Set (NTDB RDS).17 Use of these databases can expedite
clinical research and allows study of rare injury patterns using large cohorts, not possible
for the individual researcher or even individual institution. However with increased use
of these databases, it is critical to understand how the database populations differ, and
how patients are included and excluded from each, before conclusions can be made and
generalized to external populations.
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Figure 1: Database studies published in orthopaedic surgery journals have increased since the year 2000.
Studies utilizing the Nationwide Inpatient Sample (NIS), the National Surgical Quality Improvement
Program (NSQIP), or the National Trauma Data Bank (NTDB) were identified from a PubMed search of
the top 41 orthopaedic journals as defined by Moverly, et al.1 Publications in 2014 include only journals
published (electronically or in print) by September 9, 2014.

Previous comparisons of databases have focused on differences in quality of
various data elements, namely patient comorbidities and adverse events, in similar patient
populations. These studies of patients undergoing lumbar vertebral fusions,18 hip fracture
fixation,19 pancreaticoduodenectomy,20 and esophageal resection21 identified considerable
differences in the recording of comorbidities and adverse events between
administratively-coded databases, such as NIS, and registry databases, such as NSQIP.
These studies, however, focused on patient populations that were largely similar in terms
of basic demographics between databases.
Regarding high-energy orthopaedic trauma, various databases may differ in what
patients are included due to varying inclusion criteria. However of the databases cited
above, all three have been used extensively for orthopaedic trauma research,7, 22-30 with
little prior discussion of how the populations may actually compare to the true general
population of orthopaedic trauma patients. As orthopaedic trauma is an area where
database research may provide particular insights, it is critical to understand the various
differences between orthopaedic trauma populations in various national databases. The
current retrospective cohort study aims to determine (1) how the populations of patients
with femoral shaft fractures, a common high-energy injury, differ in these three
commonly used national databases, specifically in regards to age and preexisting
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comorbidities, and (2) how these differences may affect studies of in-hospital adverse
events observed in each population.
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Patients and Methods
Study design and setting
A retrospective cohort study was performed using NIS, NSQIP, and NTDB RDS.
For NSQIP and NTDB, data from 2011 and 2012 were used. Only 2011 data were used
for NIS, as 2012 data were not available at the time of study. The study was approved by
the local institutional human investigations committee.

Participants/study subjects
ICD-9 procedure codes were used to identify patients undergoing surgical
treatment of femoral shaft fractures in NIS and NTDB (ICD-9 79.05, 79.15, 79.25,
79.35). Current Procedural Terminology (CPT) codes were used to identify the same
population in NSQIP (CPT 27500, 27502, 27506, 27507). Differing methods for the
identification of patients were necessary due to differing the data elements within each
database.

Variables, outcome measures, data sources, and bias
Patient age, comorbidities, and adverse events were analyzed. Within all three
databases, binary variables were used to assess comorbidities. Seven comorbidities with
equivalent definitions across the three databases were analyzed: alcoholism,
coagulopathy, diabetes mellitus, cancer, hypertension, obesity, and current smoker status.
Appendix 1 lists specific data elements used to identify comorbidities in each database.
A modified Charlson comorbidity index (CCI) was then calculated using the seven
comorbidities analyzed and patient age. Similar to the original index,31 the modified CCI
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assigns one point for each comorbidity diagnosis (except for disseminated cancer, as in
original CCI six points are assigned due to poor life expectancy). One point was then
added for each decade greater than 40 years of age. A modified CCI has been shown to
have comparable predictive value to the original CCI,32 and has been used previously
with national databases such as NSQIP.8
Adverse events were assessed using binary variables in NTDB and NSQIP and
ICD-9 diagnosis codes in NIS. As NSQIP contains data on adverse events occurring up to
30 days postoperatively, while NTDB and NIS contain only inpatient data, adverse events
occurring after discharge in NSQIP were excluded. Nine adverse events with equivalent
definitions across databases were analyzed: acute kidney injury (AKI), cardiac arrest,
cerebrovascular accident (CVA), death, deep vein thrombosis or pulmonary embolism
(DVT/PE), myocardial infarction (MI), pneumonia, surgical site infection (SSI), and
urinary tract infection (UTI). Mortality rate, serious adverse event (SAE) rate (death,
cardiac arrest, MI, CVA, DVT/PE, and SSI), and all adverse event (AAE) rate were
computed. Appendix 2 lists specific data elements used to identify adverse events in each
database.

Statistical analysis, study size
Several different analyses were conducted in this study. First, age was compared
between populations. Mean age was compared using analysis of variance (ANOVA) and
age was plotted on a histogram. CCI was similarly compared between populations. Mean
CCI was compared using ANOVA and CCI was plotted on a histogram.
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Next, comorbidities were compared between databases. Rates of each of the seven
comorbidities analyzed were compared between databases using Pearson’s chi squared
statistic. The relative risk of each comorbidity was then estimated for both NSQIP and
NTDB compared to NIS as a reference, and then NSQIP compared to NTDB as a
reference. This was done using Poisson regression with robust error variance using an
indicator variable to designate the database. As Poisson regression overestimates the error
for relative risk when using binomial data, robust error variance was used to directly
estimate the error for the relative risk. NIS was chosen as the denominator for both
comparisons as this is thought to be the most nationally representative patient population.
Concerning adverse events, rates of mortality, serious adverse events (SAE), and
any adverse event (AAE), were computed for each population. Pearson’s chi square
statistic was used to compare rates between populations. Multivariate ANOVA was then
used to compare the rates after adjusting for age and CCI.
Finally, a simulated theoretical analysis of risk factors associated with inpatient
adverse events was conducted for each database population. Multivariate logistic
regression was used to determine the association of the age and the seven individual
comorbidities previously studied with the rate of AAEs.
All statistical analyses were performed using Stata® version 13.0 (StataCorp, LP,
College Station, Texas, USA). All statistical tests were two-tailed, and the level of
significance was set at α = 0.05.
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Results
A total of 25,121patients undergoing surgical repair of a femoral shaft fracture
were identified and included in this study. There were 3,943 patients identified and
included within NIS (2011 only, 2012 data was not available at time of study), 663
patients identified and included within NSQIP (2011-2012), and 20,515 identified and
included within NTDB (2011-2012).
The mean age of patients in NIS was 56.9 years (standard deviation [SD]: 24.9
years). The mean age of patients in NSQIP was 71.5 years (SD: 15.6 years). The mean
age of patients in NTDB was 45.2 (SD: 21.4 years). Differences in mean age between
databases were statistically significant (p < 0.001). Both NSQIP and NTDB round ages
greater than 90 to a value of 90 to prevent breach of privacy. The distribution of ages is
markedly different between NSQIP (primarily older patients) and NTDB (primarily
younger patients), with the bimodal distribution in NIS seemingly representing a more
mixed population (Figure 2).
The mean CCI of patients in NIS was 3.2 (SD: 2.3). The mean CCI of patients in
NSQIP was 4.9 (SD: 1.9). The mean CCI of patients in NTDB was 2.1 (SD: 2.0).
Differences in mean CCI between databases were statistically significant (p < 0.001).
Similar to age, the distribution of CCI is markedly different between patients in NSQIP
(more comorbidities) and NTDB (primarily fewer comorbidities), with NIS seemingly
representing a more mixed population with a bimodal distribution (Figure 3).
Rates of all individual comorbidities were greatest in the NSQIP population,
except for alcoholism and current smoker status, which were greatest in the NTDB
population (Figure 4). Incidence rates in the NIS population were in between the
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incidence rates in the NTDB and NSQIP populations for all seven comorbidities. The
relative risks of each comorbidity in the NSQIP population was statistically significant
when compared to NIS as a standard (p < 0.05), except for diabetes (p = 0.173) and
current smoker status (p = 0.184). The relative risks of all comorbidities in the NTDB
population were statistically significant when compared to NIS as a standard (p < 0.05).

Figure 2: Age of femoral shaft fracture patients vary by database. Histograms are of age distributions
within the Nationwide Inpatient Sample (NIS), the National Surgical Quality Improvement Program
(NSQIP), and the National Trauma Data Bank (NTDB). Note that NSQIP and NTDB truncate ages greater
than 90 to age = 90.
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Figure 3: Charlson Comorbidity Index of femoral shaft fracture patients vary by database. Histograms are
of CCI distributions within NIS, NSQIP, and NTDB.

Figure 4: The rates of individual comorbidities vary by database. On left are bar graphs of incidence rates
in the NIS, NSQIP, and NTDB populations. On right are bar graphs of relative risks (computed using
Poisson regression with robust error variance) of comorbidities in NSQIP and NTDB compared to NIS as a
reference. Asterisks (*) indicate statistically significant relative risks. Error bars represent 95% confidence
interval of relative risks.
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The differences in mortality rate between the different databases (range 1.1%
[NIS] to 2.0% [NSQIP]; Figure 5) were not statistically significant before risk adjustment
(P = 0.059), however after adjusting for age and CCI the differences became significant
(P < 0.001). The differences in SAE rate between the different databases (range 5.1%
[NIS] to 7.4% [NTDB]) were statistically significant before and after risk adjustment (P
< 0.001, P < 0.001). The differences in AAE rate between the different databases (range
9.1 [NSQIP] to 21.6% [NIS]) were statistically significant before and after risk
adjustment (P < 0.001, P < 0.001).

Figure 5: Adverse event rates in femoral shaft fracture patients vary by database. Bar graphs indicate
incidence rates of mortality, serious adverse events, and all adverse events in the NIS, NSQIP, and NTDB
populations. The p-values are given for Pearson’s Chi Square statistic for the distribution of adverse events
amongst databases. Statistically significant findings (p < 0.05) are indicated by asterisks and boldface.

In the simulated theoretical analysis there were several differences in the
identified risk factors for inpatient adverse events (Table 1). In the NIS population older
age was associated with increased AAEs (odds ratio [95% confidence interval]: 4.12
22

[2.82 - 6.01]), while younger age was associated with decreased AAEs (0.57 [0.39 0.84]). Old age is similarly associated with increased AAEs in the NSQIP population
(5.56 [1.13 – 27.42]). However, in the NTDB population, older age (in the 60-69, 70-79,
and 80+ age groups) is associated with fewer AAEs (0.78 [0.65 – 0.92]). Similarly,
diabetes is associated with more AAEs in the NIS population (1.40 [1.14 – 1.72]) and in
the NTDB population (1.41 [1.23 – 1.61]), and with fewer AAEs in the NSQIP
population (0.41 [0.18 – 0.95]). Additionally, for 4 of the 6 additional comorbidities
studied (alcoholism, smoking, obesity, and disseminated cancer), there was a change in
the statistical significance of the association with AAEs.
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Table 1: Theoretical analysis of risk factors associated with inpatient adverse events after
femoral shaft fractures in three commonly used national clinical databases
NIS (n = 3,951)
Odds ratio (95%
confidence
P-value
interval)

NSQIP (n = 663)
Odds ratio (95%
confidence
P-value
interval)

NTDB (n = 20,501)
Odds ratio (95%
confidence
P-value
interval)

Alcoholism

1.22 (0.84 - 1.77)

0.296

0.00 (omitted)*

-

1.39 (1.23 - 1.57)

< 0001

Smoking

0.60 (0.44 - 0.81)

0.001

1.68 (0.77 - 3.69)

0.196

0.86 (0.77 - 0.96)

0.010

Diabetes

1.40 (1.14 - 1.72)

0.001

0.41 (0.18 - 0.95)

0.038

1.41 (1.23 - 1.61)

< 0001

Hypertension

1.04 (0.86 - 1.26)

0.699

1.54 (0.82 - 2.89)

0.182

1.06 (0.95 - 1.19)

0.300

Bleeding
Obesity

1.87 (1.41 - 2.48)
1.63 (1.25 - 2.14)

< 0.001
< 0.001

2.06 (1.03 - 4.12)
1.15 (0.60 - 2.19)

0.041
0.676

1.94 (1.62 - 2.31)
1.62 (1.41 - 1.87)

< 0001
< 0001

Cancer

2.09 (1.00 - 4.34)

0.049

1.04 (0.38 - 2.85)

0.938

0.89 (0.50 - 1.61)

0.705

18 - 29

0.57 (0.39 - 0.84)

0.005

0.00 (omitted)*

-

0.69 (0.60 - 0.79)

< 0001

30 - 39

0.86 (0.56 - 1.31)

0.477

0.00 (omitted)*

-

0.86 (0.73 - 1.00)

0.051

40 - 49

1.26 (0.82 - 1.92)

0.29

2.52 (0.33 - 19.38)

0.374

1.04 (0.89 - 1.22)

0.581

50 - 59

Reference

Reference

-

Reference

-

60 - 69

1.38 (0.96 - 2.00)

0.086

3.53 (0.74 - 16.81)

0.113

0.72 (0.61 - 0.85)

< 0001

70 - 79

1.53 (1.07 - 2.18)

0.019

4.81 (1.06 - 21.74)

0.041

0.66 (0.55 - 0.79)

< 0001

80 - 89

2.84 (2.02 - 3.99)

< 0.001

3.82 (0.81 - 17.92)

0.09

0.78 (0.65 - 0.92)

0.004

90 +

4.12 (2.82 - 6.01)

< 0.001

5.56 (1.13 - 27.42)

0.035

-

-

Age

Note: NIS = Nationwide Inpatient Sample, NSQIP = National Surgical Quality Improvement Program, NTDB
= National Trauma Data Bank
*Categories were omitted from NSQIP analysis that perfectly predicted absence of adverse events
in multivariate analysis
Light shading indicates statistically significant odds ratio with positive association with inpatient adverse
events
Dark shading indicates statistically significant odds ratio with negative association with inpatient adverse
events
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Discussion
The field of orthopaedic surgery has seen increased use of large national
databases for clinical research recently. Over the past three years there has been over a
200% increase in peer-reviewed publications utilizing NIS, NSQIP, and NTDB, in
orthopaedic journals alone (Figure 1). In the field of orthopaedic trauma, national
database use has increased as well, likely due to increased use of trauma-specific
databases such as NTDB. However, as the current study indicates, various commonly
used national clinical databases treat trauma patients very differently, and the resulting
differences in database populations lead to significant differences in observed outcomes.
After comparing all patients with surgically treated femoral shaft fractures in NIS,
NSQIP, and NTDB, the current study found that the NSQIP and NTDB populations are
strikingly different, when considering age and comorbidities. The NTDB population is
younger and has fewer preexisting comorbidities, while the NSQIP population is older
and has more preexisting comorbidities. The NIS population appears to be bimodal in
terms of age and comorbidities. While previous database comparisons have primarily
focused on differences in specific data elements among demographically similar
populations,19-21 the current study is the first to highlight the significant demographic
differences of trauma populations in national databases that are each commonly used for
orthopaedic trauma research.
As expected, the observed differences in populations also lead to differences in
outcomes. There were statistically significant differences in the rates of mortality, SAEs,
and AAEs between the three database populations, after controlling for age and CCI.
Interestingly mortality was not significantly different between populations, likely due to

25

the low overall mortality rate among femoral shaft fracture patients (ranging from 1.1 2.0%). In our theoretical study of risk factors for inpatient adverse events, there were
several differences in the simulated results. Most striking was the change in directionality
of the association of certain risk factors (diabetes, older age) with adverse events,
depending on the database studied. This illustrates the importance of understanding the
database population being studied before attempting to generalize results of a study to
other clinical populations.
The differences in database populations demonstrated in the current study
highlight the relative strengths and weakness of each database (Table 2). Based on
sampling methodology, NIS is the most nationally representative and comprehensive
sample. NSQIP and NTDB include only data from voluntarily participating institutions,
and are likely biased towards larger hospitals that have interests in quality monitoring and
improvement. In contrast the Hospital Cost and Utilization Project takes data from all
inpatient discharges from a nationally representative sample of community hospitals
(approximately 20% of all U.S. community hospitals). While this is a relative strength of
the NIS dataset, the quality of the billing code data it contains has previously been called
into question.33-35 NIS contains strictly ICD-9 billing code diagnoses compared to NSQIP
and NTDB, which utilize chart-abstracted diagnoses for comorbidities and adverse
events. ICD-9 coding inconsistencies have been noted in past studies comparing
databases with administratively-coded versus chart-abstracted data. 19, 33-36 As
administrative billing codes are subject to economic and political pressures, there is
potential for underreporting or over-reporting certain diagnoses.
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Table 2: Comparison of three commonly used national clinical databases
Nationwide Inpatient
Sample (NIS)

National Surgical Quality
Improvement Program
(NSQIP)

National Trauma Data Bank
(NTDB) Research Data Set
(RDS)

Overseeing
organization:
Earliest year
available:
Participating
hospitals:

Healthcare Cost and
Utilization Project (HCUP)
1988

American College of
Surgeons
2005

American College of
Surgeons
2007

Stratified systematic
sample from all HCUP
hospitals (equivalent to
20% of all discharges from
U.S. community hospitals).

Any voluntarily
participating institution

Patient inclusion
criteria:

All inpatient discharges

Data collection
methods:

Hospital billing codes

Number of cases
(2011):
Number of
hospitals (2011):
Number of
variables reported:
Diagnosis coding:
Number of
diagnoses
reported:
Procedure coding:
Number of
procedures
reported:
Procedure timing:
Pre-hospital data?
Post-discharge
data?
Comorbidity data
source:

8,023,590

NSQIP participant
institutions (requires
annual membership
renewal and NSQIP
surgical clinical reviewer
on staff)
Systematic sampling
(every 8 days) of hospital's
daily surgical log. Hospital
may include
general/vascular cases only
or multispecialty. Most
acute trauma, transplant,
and minor surgical cases
excluded.
Chart review by SNIPtrained surgical clinical
reviewer with regular interrater reliability audits
442,149

1,049

315

744

187

252

116

ICD-9
Multiple

ICD-9
Single preoperative
diagnosis

ICD-9
Multiple

ICD-9
Multiple

CPT
Multiple

ICD-9
Multiple

By day
Not available
Not available

By hour
From initial EMS dispatch
No

Adverse events
data source:

ICD-9 diagnosis codes

By day
Not available
Up to 30 postoperative
days
Chart-review by surgical
clinical reviewers using
NSQIP comorbidity
definitions
Chart-review by surgical
clinical reviewers using
NSQIP adverse event
definitions

ICD-9 diagnosis codes
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All trauma cases (based on
ICD-9 diagnosis) resulting
in inpatient admission or
death.

Institution dependent (chart
abstraction/ billing code
data)
773,299

Institution dependent (Chartreview/ICD-9 codes). ND
recommended comorbidity
definitions.
Institution dependent Chartreview/ICD-9 codes).
NTDB recommended
adverse event definitions.

The ACS NSQIP is primarily geared towards elective surgery, with some
institutions only reporting elective general surgery and vascular surgery cases. Most acute
trauma and transplant procedures are excluded. Review of NSQIP data collection
guidelines for surgical clinical reviewers indicates that most high energy mechanisms of
injury are excluded from the database, such as motor vehicle accidents and firearms.37
Lower energy mechanisms that are included consist of falls from standing or from up to 3
steps resulting in non-penetrating, single-bone or single organ system injury.37 Therefore,
the fracture population contained in NSQIP likely consists largely of patients with
preexisting comorbidities such as osteoporosis, preexisting prostheses, prior fractures or
nonunions, or bony metastasis, all resulting in weaker bone stock and higher likelihood of
fracture with lower energy mechanisms. Nevertheless, despite NSQIP including only a
small subset of all fractures, studies have been published utilizing NSQIP to draw
conclusions regarding orthopaedic trauma patient populations.19, 28-30 While NSQIP does
have the most reliable data collection system, including specially trained NSQIP surgical
clinical reviewers and regular inter-rater reliability audits; trauma researchers should
carefully consider whether NSQIP truly captures the intended population before using the
database for clinical studies.
In contrast, NTDB likely contains the best representation of the acute high-energy
fracture patient population. All patients admitted through the emergency department at
participating institutions with a trauma-specific ICD-9 diagnosis code (800.0 – 959.9)
meet NTDB inclusion criteria.17 However, these criteria do not include pathologic
fractures (ICD-9 733.1X), stress fractures (733.9X), or fracture nonunions and malunions
(733.8X). These reasons help explain why the population of surgically treated femoral
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shaft fracture patients in NTDB is primarily younger patients, likely with higher-energy
mechanisms of injury.
No database serves as a “gold standard” for study of trauma populations. Rather,
study of each of these individual trauma populations does have merit. Femoral shaft
fractures represent a spectrum of injuries resulting from both low-energy and high-energy
mechanisms, as demonstrated by the bimodal age distribution seen in NIS. As a true
national sampling of inpatients, NIS would be ideal for national-level demographic and
incidence studies of all types of femoral shaft fracture patients. Studies intending to focus
on osteoporotic type stress fractures would be well suited to the NSQIP population. On
the other hand, NTDB is skewed toward younger, high-energy patients seen at Level I
and II, and is best suited for study of this unique population. 17
Furthermore, each of the databases offers unique data elements that allow for
differing study opportunities. NSQIP has several unique intraoperative variables (i.e.
operative time, anesthesia type, intraoperative transfusion) in addition to documentation
of adverse events that occur up to 30 days after surgery (often after discharge). NTDB
contains detailed pre-hospital variables, such as ambulance time and mechanism of
injury, and emergency department variable. NIS, in contrast, largely contains only data
derived from ICD-9 billing codes, but is useful due to its nationally weighted sampling
from all U.S. inpatient admissions.
The primary limitation of this study is the lack of hospital specific identifiers that
could be matched between databases. This would allow comparison of the patient
samples obtained from the same institutions. However, in order to maintain anonymity of
the participating institutions, these data are not present in any of the three databases.
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While it is impossible to tell whether differences in populations are due to differences in
the institutions included versus differences in how trauma patients are included within
individual institutions, the differences observed are still significant and warrant careful
consideration for future studies.
When planning database studies, careful consideration must be made to ensure
researchers and those evaluating database research fully understand the populations being
studied. Due to large sample sizes, statistically significant results may be drawn from
each database. Therefore appreciation of population demographics and database inclusion
criteria is imperative to ensure that the conclusions drawn are indeed valid and are
generalized to the appropriate clinical populations.
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Section II

Using a National Database and Subsequently an Institutional Cohort to Identify
Potentially Modifiable Risk Factors for Delayed Hip Fracture Surgery: An example
of using databases for hypothesis discovery

Submitted as:

Samuel AM, Varthi AG, Fischer JM, Lukasiewicz AM, Webb ML, Bohl DD,
Basques BA, Lane JM, Grauer JN. “Using a national database and subsequently
an institutional cohort to identify potentially modifiable risk factors for delayed
hip fracture surgery” Clin Orthop Relat Res (Submitted January 2016)
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Background
There is considerable evidence associating earlier surgery after elderly hip
fracture with reduced mortality 38-45, shorter length of stay 39, 44, 46, improved discharge
disposition 44, 47, and fewer complications 48. Currently, both in the United States and
United Kingdom, national orthopaedic practice guidelines support early operative
management and mobilization of these patients. In 2010, the England and Wales
Department of Health instituted a Best Practice Tariff providing financial incentives for
hospital to follow a specified care pathway for patients with hip fractures, including
surgery within 36 hours of admission 49, 50. In 2014 the American Academy of
Orthopaedic Surgeons (AAOS) released a Clinical Practice Guideline, entitled
Management of Hip Fractures in the Elderly, recommending surgery within 48 hours of
admission for all elderly hip fracture patients 51. In addition, a recent Danish cohort study
demonstrated that surgical delay past 12 hours was associated with increased rates of 30day mortality 52. With the Canadian Hip Fracture Accelerated Surgical Treatment And
Care Track Trial (HIP ATTACK) now ongoing 53, examining potential benefits of
accelerated surgery within 6 hours, it is possible that clinical evidence and national
bodies will further support even earlier surgical intervention in these patients.
With the growing literature supporting early and accelerated surgical management
of elderly hip fractures, there is a need to identify means to reduce our current
preoperative time in the most efficient means possible. A recent cohort study of 2 million
patients in the National Inpatient Survey (NIS) database identified risk factors for delayed
surgery: race, Medicaid insurance, Northeastern hospital location, and higher comorbidity
scores were associated with delayed surgical management 54. However, these factors are
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large non-modifiable. In addition, the authors did not comment on the marginal effect of
various risk factors on overall surgical timing. The current analysis first utilizes a large
national cohort to identify medical comorbidities that may predispose patients to surgical.
Next, based on the results from the national cohort, a more focused analysis of more
modifiable risk factor was conducted using a cohort from a single academic trauma
center. The authors of the present study also hope to present a new paradigm for clinical
research using national databases, utilizing a national cohort first to better focus the
analysis of a local cohort.
The objectives of this study are to answer the following: (1) What risk factors are
associated with delays to surgery in a national cohort? (2) What modifiable risk factors
are associated with delays to surgery within in our institutional cohort?
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Patients and Methods
Study Design and Setting
Two separate populations were studies. First a retrospective cohort study was
conducted using the 2011-2012 American College of Surgeons (ACS) National Trauma
Data Bank (NTDB). NTDB is the largest national database of trauma cases, including
cases from over 900 voluntarily participating trauma centers across the United States17.
Next, a retrospective cohort study was conduct at a single academic trauma center located
in an urban setting.

Participants/Study Subjects
In both the national and institutional cohorts patients were identified using
International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes All
patients aged 65 years or greater with femoral neck fractures (820.0X, 820.1X),
intertrochanteric fractures (820.2X, 820.3X), or unspecified hip fractures (820.8, 820.9)
were included in the study. The NTDB cohort included patients from admission years
2011 and 2012, while the institutional cohort included patients from admission years
2009 to 2015. The following ICD-9 procedure codes were then used to identify patients
that underwent surgical fixation: 79.15 (closed reduction and internal fixation of the
femur), 79.35 (open reduction and internal fixation of the femur), 81.52
(hemiarthroplasty of the hip), 81.51 (total arthroplasty of the hip), and 81.40 (repair of
hip, not elsewhere classified).
All patients without ICD-9 codes for surgical fixation or with missing data
regarding time to surgical fixation were excluded. Furthermore, as the NTDB contains a
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disproportionate number of high-energy trauma patients from level-one trauma centers,
only patients with Injury Severity Score < 9 were included in this population, to best
represent the population of patients suffering typical elderly fragility fractures of the hip.
An Injury Severity Score of 9 corresponds with a single, isolated hip fracture.

Description of experiment, treatment, or surgery
All patients underwent surgical treatment of their hip fracture during initial
hospital admission in both cohorts. Patient were categorized based on the type of surgical
procedures: closed reduction and internal fixation of the femur (CRIF), open reduction
and internal fixation of the femur (ORIF), hemiarthroplasty of the hip, total arthroplasty
of the hip, and repair of the hip not elsewhere classified.

Variables, outcome measures, data sources, and bias
In the national cohort, the following risk factors for delayed surgery were
analyzed: gender, age, coagulopathy (including anticoagulation), congestive heart failure
(CHF), coronary artery disease, obesity, chronic respiratory disease, functionallydependent status, diabetes mellitus, type of fracture (femoral neck or intertrochanteric),
type of surgery (CRIF, ORIF, hemiarthroplasty, total arthroplasty), and type of hospital
(academic or non-academic). Age, gender, comorbidities, and hospital type are reported
in NTDB as chart-abstracted data elements. Fracture classification and type of surgery
are reported as ICD-9 codes.
After review of initial results from the national cohort, more focused risk factors
were identified for analysis in the institutional cohort. Gender was analyzed while age
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was not, as this was not significant even in the large national cohort. As coagulopathy
was a significant risk factor in the national cohort, in the institutional cohort preoperative
anemia (hematocrit < 30%), chronic warfarin anticoagulation therapy, other chronic
anticoagulation therapy, and regular aspirin use were studied as risk factors. As CHF was
a significant risk factor in the national cohort, recent exacerbation of CHF symptoms and
inpatient furosemide therapy were studied as risk factors. Coronary artery disease,
obesity, and transfer from an outside hospital (OSH) were studied as risk factors. In
addition, type of hip fracture and type of surgery were studied as in the national cohort.
All patient level data was determined based on chart-review or ICD-9 coding (for fracture
type and surgery type).
The primary outcome measure in this study is surgical timing. Time from initial
hospital admission to start of surgical intervention was calculated for each patient.
Surgical start time was defined as time of initial incision.

Statistical analysis, study size
The mean (and standard deviation) time to surgery was computed in each cohort.
In addition, the mean (and standard deviation) time to surgery was determined for
patients with each risk factor studied. Multivariate regression analysis was used to
determine the independent effect of each risk factor on surgical timing (in hours) in both
cohorts. In the national cohort, 44,900 patients were analyzed. In the institutional cohort,
1,196 patients were analyzed.
All statistical analyses were performed using Stata® version 13.0 (StataCorp, LP,
College Station, Texas, USA). All statistical tests were two-tailed and the level of
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statistical significance was set at α = 0.05. In order to reduce risk of a type 1 error, a
Bonferroni correction was used to determine the threshold for statistical significance.
Based on the 18 different hypotheses tested, the level of statistical significance was
reduced to α = 0.003.

Demographic, description of study population
Of the 44,900 patients in the national cohort, 32,337 (72%) were female and
12,563 (28%) were male. The median age was 81 years (interquartile range [IQR]: 74 –
85; note that NTDB limits maximum age to 89 years). A total of 18,983 patients had
intertrochanteric fracture (42%), while 7,390 had femoral neck fractures (16%), and
18,527 had unspecified hip fractures (41%). A total of 11,069 patients underwent CRIF
surgery (25%), 19,030 underwent ORIF surgery (42%), 12,904 underwent
hemiarthroplasty surgery (29%), and 1,897 underwent total arthroplasty surgery (4%).
Of the 1,196 patients in the institutional cohort, 866 (72%) were female and 330
(28%) were male. The median age was 85 years (interquartile range [IQR]: 78 – 90). A
total of 626 patients had intertrochanteric fracture (52%), while 450 had femoral neck
fractures (38%), and 120 had unspecified hip fractures (10%). A total of 115 patients
underwent CRIF surgery (10%), while 699 underwent ORIF surgery (58%), 160
underwent hemiarthroplasty surgery (13%), 35 underwent total arthroplasty surgery
(3%), and 187 had an unspecified repair of the hip (16%).
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Results
National cohort
The median time to surgery in the national cohort was 24 hours (IQR: 17 – 39
hours). The distribution of time to surgery can be seen in Figure 1, with the number of
patients who would have been considered as having had appropriate early surgery as
indicated by the 2014 AAOS Guideline (86%), the 2010 UK NHS Best Practice Tariffs
(74%), and the 2015 Danish Hip Fracture Registry Study (11%).

Figure 1: Distribution of surgical timing in the national elderly hip fracture cohort
(2011 – 2012 NTDB, n = 44,900)

Patient / surgical variables for this cohort are presented in Table 1, with the
number of patients and median time to surgery indicated in the first two data columns. Of
all the risk factors for delay surgery that were studied, the highest median time to surgery
was for patients with coagulopathies at 30 hours (IQR: 20 – 48 hours), congestive heart
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failure at 28 hours (IQR: 19 – 48 hours), coronary artery disease at 28 hours (IQR: 19 –
47 hours), and total arthroplasty at 27 hours (IQR: 19 – 45).
Multivariate analysis for factors significantly associated with time to surgery was
then performed (Table 1, last two data columns). All risk factors had a statistically
significant association with time to surgery except for age. The greatest independent
effect sizes were for total arthroplasty at 7.7 additional hours (95% C.I.: 6.1 – 9.3 hours),
coagulopathy at 7.1 additional hours (95% C.I.: 6.1 – 8.0 hours), and congestive heart
failure at 6.9 additional hours (95% C.I.: 6.0 – 7.9 hours).

Institutional cohort
The median time to surgery in the institutional cohort was 25 hours (IQR: 18 – 39
hours). The distribution of time to surgery can be seen in Figure 2, with the number of
patients who would have been considered as having had appropriate early surgery as
indicated by the 2014 AAOS Guideline (85%), the 2010 UK NHS Best Practice Tariffs
(73%), and the 2015 Danish Hip Fracture Registry Study (11%).
Patient / surgical variable for this cohort are presented in Table 2., with the
number of patients and median time to surgery indicated in the first two columns. Of all
the risk factors for delay surgery that were studied, the highest median time to surgery
was for patients with total arthroplasty at 42 hours (IQR: 24 – 68 hours), inpatient
furosemide therapy for CHF exacerbation at 41 hours (IQR: 30 – 53 hours), warfarin
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Table 1: Multivariate of risk factors for surgical delay in the
national cohort
Median time
n (% of
to surgery,
Risk factor
44,900
in hours
patients)
(interquartil
e range)

Multivariate
regression coefficient,
additional hours to
surgery (95%
confidence interval)

P-value

< 0.001

Gender
Female
Male

32,337 (72%)
12,563 (28%)

23 (17 - 38)
24 (17 - 41)

Reference
2.1 (1.4 - 2.7)

Age
65- 69
70 - 74
75 - 79
80 - 84
85+

5,211 (12%)
6,161 (14%)
8,364 (19%)
12,131 (27%)
13,033 (29%)

23 (16 - 38)
23 (16 - 38)
24 (17 - 39)
24 (17 - 39)
24 (17 - 39)

Reference
-0.7 (-1.8 - 0.5)
0.3 (-0.7 - 1.4)
0.3 (-0.8 - 1.3)
-0.3 (-1.3 - 0.7)

Comorbidities
Coagulopathy
Congestive heart failure
Coronary artery disease
Obesity
Chronic respiratory disease
Functionally dependent
Diabetes mellitus

4,848 (11%)
4,824 (11%)
1,605 (4%)
1,730 (4%)
6,732 (15%)
2,386 (5%)
9,787 (22%)

30 (20 - 48)
28 (19 - 48)
28 (19 - 47)
26 (18 - 45)
25 (18 - 42)
25 (18 - 41)
25 (17 - 42)

7.1 (6.1 - 8.0)
6.9 (6.0 - 7.9)
3.8 (2.2 - 5.4)
3.7 (2.2 - 5.2)
2.9 (2.0 - 3.7)
2.2 (0.9 - 3.5)
2.0 (1.2 - 2.7)

< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
0.001
< 0.001

Fracture type (*)
Femoral neck
Pertrochanteric

7,290 (16%)
18,983 (42%)

25 (18 - 41)
23 (16 - 36)

2.3 (1.3 - 3.3)
Reference

< 0.001
-

Procedure type (*)
CRIF
ORIF
Hemi arthroplasty
Total arthroplasty

11,069 (25%)
19,030 (42%)
12,904 (29%)
1,897 (4%)

22 (15 - 33)
24 (17 - 40)
24 (17 - 40)
27 (19 - 45)

Reference
3.3 (2.6 - 4.1)
2.9 (2.0 - 3.8)
7.7 (6.1 - 9.3)

< 0.001
< 0.001
< 0.001

Non-academic hospital
Academic hospital

31,688 (71%)
13,212 (29%)

23 (16 - 37)
24 (17 - 42)

Reference
4.1 (3.4 - 4.7)

< 0.001

0.245
0.583
0.622
0.556

ORIF = open reduction and internal fixation, CRIF = closed reduction and internal fixation
Asterisks (*) indicate data elements with incomplete classification to due nonspecific coding of
fracture types or procedure types.
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anticoagulation at 40 hours (IQR: 27 – 60 hours), and other chronic anticoagulation at 36
hours (IQR: 24 – 61).

Figure 2: Distribution of surgical timing in the single-institution elderly hip fracture cohort (n = 1,196)

Multivariate analysis for factors significantly associated with time to surgery was
again performed (Table 2, last two columns). Only 5 risk factors had a statistically
significant association with time to surgery: total arthroplasty at 24.0 additional hours
(95% C.I.: 13.2 – 34.8 hours), transfer from outside hospital at 22.0 additional hours
(95% C.I.: 15.0 – 29.0 hours), warfarin anticoagulation at 13.4 additional hours (95%
C.I.: 8.2 – 18.5 hours), other anticoagulation therapy at 10.0 additional hours (95% C.I.:
1.9 – 18.0 hours), and recent CHF exacerbation at 7.7 additional hours (95% C.I.: 1.8 –
13.6 hours).
Table 2: Multivariate of risk factors for surgical delay in the institutional cohort
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n (% of
1,196
patients)

Mean time
to surgery,
in hours
(standard
deviation)

Multivariate
regression
coefficient, hours
(95% confidence
interval)

Gender
Female
Male

866 (72%)
330 (28%)

25 (18 - 37)
26 (18 - 42)

Reference
0.9 (-2.8 - 4.5)

Medical risk factors
Transfer from OSH
Warfarin anticoagulation
Other anticoagulation
Recent CHF exacerbation
Inpatient furosemide
Coronary artery disease
Hematocrit < 30
Obesity
Aspirin therapy

66 (6%)
131 (11%)
50 (4%)
99 (8%)
16 (1%)
234 (20%)
86 (7%)
25 (2%)
261 (22%)

32 (17 - 60)
40 (27 - 60)
36 (24 - 61)
29 (23 - 43)
41 (30 - 53)
28 (21 - 42)
28 (20 - 43)
27 (21 - 41)
26 (20 - 39)

22.0 (15.0 - 29.0)
13.4 (8.2 - 18.5)
10.0 (1.9 - 18.0)
7.7 (1.8 - 13.6)
5.7 (-8.2 - 19.6)
3.0 (-1.2 - 7.2)
2.3 (-3.9 - 8.5)
0.9 (-10.2 - 12.0)
0.7 (-3.2 - 4.6)

Fracture type (*)
Femoral neck
Pertrochanteric

450 (38%)
626 (52%)

27 (20 - 42)
24 (17 - 37)

1.4 (-3.0 - 5.9)
Reference

Procedure type (*)
CRIF
ORIF
Hemi arthroplasty
Total arthroplasty

115 (10%)
699 (58%)
160 (13%)
35 (3%)

24 (15 - 31)
24 (17 - 37)
27 (20 - 39)
42 (24 - 68)

Reference
4.6 (-1.0 - 10.2)
6.1 (-1.0 - 13.1)
24.0 (13.2 - 34.8)

Risk factor

P-value

0.640

< 0.001
< 0.001
0.015
0.011
0.421
0.157
0.460
0.879
0.721

0.529
-

0.104
0.095
< 0.001

OSH = outside hospital
CHF = congestive heart failure
CRIF = closed reduction and internal fixation
ORIF = open reduction and internal fixation
Asterisks (*) indicate data elements with incomplete classification to due nonspecific
coding of fracture types or procedure types.
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Discussion
Substantial existing evidence supports earlier surgery after elderly hip fractures 3848, 52

. Current national guidelines in the United States and United Kingdom recommend

surgery within 48 hours and 36 hours of admission, respectively 49-51. In addition, a recent
study using the Danish Hip Fracture Registry has shown surgery delayed later than 12
hours after admission was associated with increased 30-day mortality 52. With more
ongoing research evaluating potential benefits with even earlier surgery after hip fracture,
we may very soon see recommendations for surgery within even shorter time intervals.
These recommendations for early surgery after elderly hip fracture may even become tied
to hospital or physician reimbursement as in the U.K. In order to eventually reduce the
overall time to surgery, changes in staffing of orthopaedic surgeons will be a necessary
step.
The current study aims to identify potentially modifiable factors that may allow us
provide earlier surgery for hip fracture patients. First, patient factors were analyzed in a
national cohort of patients to identify broad factors associated with surgical delays.
Second, the findings from the national-level analysis were used to identify modifiable
factors associated with delays in an institutional cohort. While a number of factors had
significant associations with later surgery in the national cohort, focused analysis in the
institutional cohort demonstrated that management of chronic anticoagulation, recent
CHF exacerbations, patient’s requiring arthroplasty surgery, and patients transferred from
an OSH are all factors to be addressed in order to reduce overall time to surgery.
Limitations
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The current study has a number of limitations. First, as with any study using a
large clinical database, the quality of results is dependent on the quality of data contained
in the database. Fortunately, NTDB does include specific data elements for various
comorbidity diagnoses that have been shown to be more accurate than the ICD-9 billing
codes utilized in other databases 55. Nevertheless, the accuracy of data entry in NTDB is
institution-dependent and there may be inconsistencies and systematic biases. For this
reason, the current study takes the further step of verifying the results of the national
cohort analysis using an institutional cohort and conducting a more focused analysis.
A second limitation of the current study is the inability to characterize all factors
that may be related to delays in surgery. Individual cases of logistical, staffing, or clinical
delays likely occur with most patients, and cannot be well delineated even with chartreview. As a result, this study attempts to take a bird’s eye view and identify potentially
modifiable factors that may have the biggest impact on overall surgical timing. Any
large-scale attempt to reduce the overall time to surgery after trauma would likely benefit
from standardized protocols that eliminate systemic logistical and staffing delays.
National Cohort
Based on the results of our national cohort analysis, gender, all medical
comorbidities, type of fracture, type of surgery, and hospital type had statistically
significant associations with surgical timing. The largest effect sizes were for total
arthroplasty (7.7 hours), coagulopathy (7.1 hours) and congestive heart failure (6.9
hours), all of which we chose to analyze in greater detail in our institutional cohort
(Figure 3).
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Figure 3: Diagram of step-wise selection of focused, modifiable risk factors for analysis between the
national cohort and the institutional cohort. Circles indicate risk factors that were statistically significant
(light green in the national cohort represents regression coefficient s< 3.0). X’s indicate risk factors that
were not statistically significant or did not have associations with an effect size that met a predetermined
threshold. Note: CHF = congestive heart failure, Hct = hematocrit.

Coronary artery disease and obesity were two factors found to be associated with
independent delays of over 3 hours in the national cohort. One previous analysis of over
600 patients at one level 1 trauma center found that patient requiring preoperative cardiac
testing were delayed 1.5 more days prior to surgery, compared to those who are not 56,
while longer time to surgery associated with obesity has not previously been shown. Both
obesity and coronary disease are known to predispose patients to a number of
preoperative risk factors for postoperative complications, risk factors that may necessitate
preoperative cardiac, respiratory, endocrine, and volume status screening 57, 58. While this
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screening is no doubt necessary, in order to reduce surgical timing after hip fractures in
the future this screening also must be expedited for patients with body mass indices
greater than determined thresholds.
Institutional Cohort
In the institutional cohort, total arthroplasty surgery was associated with the
greatest delay (24.0 additional hours) and presumably was largely due to the lack of
availability of specialized arthroplasty surgeons who may not be available for urgent
surgery at time of patient admission. Additional risk factors that were identified were
transfers from outside hospitals, warfarin anticoagulation, other chronic anticoagulation,
and recent CHF exacerbation.
Based on these findings two modifiable aspects of hip fracture management may
be appropriate aims for future investigation. First, timely availability of the correct
surgeon and surgical staff is essential for early operative management, especially if hip
fracture guidelines are revised with earlier goals. Longer time to hip fracture surgery for
patients requiring total hip arthroplasty suggests that staffing of arthroplasty surgeons
may be lacking compared to surgeons able to perform an ORIF of a hip fracture. Urgent
total hip arthroplasty has previously been shown to be associated with higher total
hospital costs and perioperative complications compared to elective arthroplasty 59.
Nevertheless, long-term outcomes after total hip arthroplasty for elderly hip fractures are
good 60. The ongoing Hip fracture Evaluation with ALternatives of THA versus
Hemiarthroplasty (HEALTH) trial is investigating the superiority of hemi- versus totalarthroplasty after elderly hip fractures 61. If the HEALTH trial does demonstrate better
long-term outcomes with THA, then THA may become the new standard of care for
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elderly femoral neck fractures, further necessitating increased staffing of arthroplasty
surgeons. However, if the benefits of THA over hemiarthroplasty are negligible then the
large delays associated with THA may outweigh these benefits. This would then suggest
that hemiarthroplasty, performed in a timely manner, be the treatment of choice. The
growing concept of specialized hip fracture services, with expedited pathways to
appropriate surgical treatment may be a suitable solution 62-64.
A second aspect of care that may be modified is medical co-managemnt of hip
fracture patients. Both warfarin and alternative therapies for chronic anticoagulation were
associated with large delays to surgery (13.4 and 10.0 additional hours, respectively).
This accounted for 15% of our institutional cohort (177 patients). Reversal of chronic
anticoagulation prior to surgery is clearly necessary to avoid excessive bleeding.
However, with more pressure to operate on hip fracture earlier, more rapid medical
strategies for reversal may be warranted. This may be optimally managed by an inpatient
medical service that is co-managing hip fracture patients in concert with the surgical
team. Previous studies of prothrombin complex concentrate (PCC) for reversal of vitamin
K antagonist anticoagulation, have shown good safety and effectiveness when used prior
to acute surgery 65, even when compared to fresh frozen plasma 66. While this relatively
new treatment is expensive, several analyses have demonstrated that use of PCC for rapid
warfarin reversal after hip fractures is actually cost effective, due to reduce preoperative
hospital time and shorter postoperative length of stay 67-69. Adoption of rapid warfarin
reversal protocols by medical teams may be a very effective method to reduce time to
surgery for a large subset of hip fracture patients. For patients taking new oral
anticoagulants (NOACs), PCC has also been shown to effectively reverse both the factor
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Xa inhibitor rivaroxaban and the thrombin inhibitor dabigatran in one prospective
randomized controlled trial 70. Recent CHF exacerbations were also associated with a
delay to surgery of 7.7 hours in the institutional cohort. This was largely due to need for
preoperative medical screening and the rare circumstance of a patient presenting acute
with decompensated CHF. Co-management by a medical team with standardized
preoperative screening algorithms for patients with preexisting CHF may help to more
rapidly identify patients who are too high-risk for surgical intervention.
Conclusion
In conclusion, the current study utilizes a large national cohort and an institutional
cohort to identify modifiable risk factors for delayed hip fracture surgery. Based on the
current findings, more aggressive reversal of chronic anticoagulation would be an
effective mean to reduce delays in a large subset of the population. Standardized
preoperative screening algorithms, which focus on identifying patients who are poor
surgical candidates, would also help reduce preoperative delays. Additionally, if use of
total hip arthroplasty to manage hip fractures increases, bases on current ongoing clinical
trials, improved staffing of arthroplasty surgeons may also be warranted. Ultimately, with
the growing body of research showing benefits with hip fracture fixation within 24 hours
or even earlier, strategies for reducing our current preoperative interval are necessary.
While standardized admission protocols and order sets will be necessary to reduce
logistical and administrative delays, the current study identifies certain patient factors that
providers should also be prepared to manage aggressively in order to achieve optimal
surgical timing.
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Section III

Variation in Resource Utilization for Hip and Pelvic Fracture Patients, Despite
Equal Medicare Reimbursement: An example of using databases for hypothesis
testing
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Background
The current Medicare Acute Inpatient Prospective Payment System determines
hospital reimbursement for inpatient admissions by categorizing patients into Diagnosisrelated Groups (DRGs), originally meant to create patient classes that are “clinically
consistent and that have similar patterns of output utilization” 71. When first
implemented in 1983, the DRG model represented a substantial shift away from
traditional cost-based billing, transferring both risk and potential cost-savings to hospitals
72

. Regardless of true hospital costs, all inpatient admissions under the same DRG are

reimbursed using the same “bundled” payment, the only exception being a
reimbursement modifier for either major or minor patient complications and/or
comorbidities.
Although the DRG system has no doubt resulted in Medicare cost savings, proper
division of patients into DRGs is critical to prevent under-reimbursement to hospitals or
wasted Medicare payments. Under the current Medicare Severity (MS)-DRG system,
MS-DRG 536 (fractures of the hip and pelvis) encompasses a large number of elderly
orthopaedic trauma patients. While the age-adjusted incidence of elderly fractures has
declined since 2005, the absolute incidence has increased dramatically due to the growing
elderly population and is expected to continue to grow 73, 74. The U.S. population older
than age 85 is expected to increase 3-fold between 2010 and 2050 73. In addition, elderly
fractures can be costly to manage, as they often require surgical intervention. However,
the average low-energy hip fracture and high-energy pelvic fracture, both included in
DRG 536, are considerably different injuries with differing management courses and,
likely, differing associated inpatient costs 75. Due to the common nature of these injuries,
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these differences in costs may account for substantial sums. Classification of other
Medicare DRGs for procedures such as total joint arthroplasty, spinal fusion, and
coronary artery bypass grafting has been modified to take into account cost variations 76,
77

. For example due to higher hospital costs associated with revision arthroplasty, versus

primary arthroplasty, these procedures were separated into a separate DRG with greater
reimbursement rates 76-78. As the complexities of our current US healthcare environment
make estimation of true healthcare costs difficult, several measures of hospital resource
utilization were used as proxies for inpatient costs. In this way, differences in utilization
can also be translated across health systems, regardless how cost accounting practices
differ between individual institutions.
The purpose of this study was to determine whether (1) inpatient length of stay;
(2) intensive care unit (ICU) stay; and (3) ventilator time differ between subpopulations
of Medicare DRG 536, even after controlling for hospital factors.
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Patients and Methods
A retrospective study was performed using the 2011 and 2012 American College
of Surgeons National Trauma Data Bank Research Data Set. The National Trauma Data
Bank is the largest national database of trauma cases including patients from over 900
trauma centers annually. While other commonly studied national databases, such as the
National Surgical Quality Improvement Program database, do not include non-operative
patients or high-energy trauma patients, the National Trauma Data Bank allows analysis
of both operative and non-operative patients sustaining both high-energy and low-energy
injuries in centers across the U.S, or the full spectrum of patients in DRG 536. In
addition, there are currently a number of methodologies used by healthcare economists
and hospital administrators to calculate costs, with no consensus between institutions or
researchers. The National Trauma Data Bank offers data on various measure of
healthcare resource utilization, namely inpatient length of stay, ICU stay, and mechanical
ventilation time, which may be used as proxies for inpatient costs. In this way,
differences in utilization can also be translated across health systems, regardless of the
differing cost accounting practices of individual institutions Human investigations
committee approval was acquired before initiating the study.
International Classification of Diseases, 9th Revision (ICD-9) diagnosis codes
were used to identify patients in MS-DRG 536 based on diagnoses of acetabulum
fractures, including both operative and non-operative, (ICD-9 808.0–808.1), other pelvic
fractures (ICD-9 808.2–808.59), and hip fractures (ICD-9 820.20–820.32). Patients with
other pelvic fractures were further subdivided into operative and non-operative pelvic
fracture-based ICD-9 procedure codes (ICD-9 79.19, 79.29, 79.39, or 79.49). Note that
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patients managed operatively versus non-operatively, or with internal fixation versus
arthroplasty, would similarly be grouped into MS-DRG 536, regardless of ultimate
treatment modality. Only patients within the Medicare age group (65 years or older) were
included.
A retrospective study was performed comparing inpatient length of stay, intensive
care unit stay, and ventilator time among the four subpopulations of Medicare DRG 536.
The three resource utilization measures of interest were reported as continuous variable in
the National Trauma Data Bank. Multivariate analysis controlled for possible
confounding patient and hospital factors including Charlson Comorbidity Index, hospital
teaching status (university, community, or nonteaching), hospital size (≤ 200 beds, 201–
400 beds, 401–600 beds, or > 600 beds), and geographic region (by US Census regions:
Northeast, Midwest, South, and West). The modified Charlson Comorbidity Index has
been shown to have comparable predictive value to the original Charlson Comorbidity
Index and have been used previously in studies of national databases with national
databases studies 7, 8, 32. Computation of the modified Charlson Comorbidity Index was
based on National Trauma Data Bank comorbidity and age data (Appendix 1;
Supplemental materials are available with the online version of CORR®.). The hospital
factors are reported in National Trauma Data Bank by participating institutions. Two
additional possible confounding variables are month of admission and American College
of Surgeons trauma center level. Previous studies have demonstrated that length of stay
may vary according to a seasonal or “July” effect and by American College of Surgeons
level. Unfortunately data on date or month of admission in unavailable in the database
and data on American College of Surgeons level contains a large amount of missing data
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(36%). However, as contributing trauma centers submit a full year of patient data to the
National Trauma Data Bank, most seasonal variations can be expected to wash out. In
addition, controlling for teaching status (non-teaching, community, or university) and
hospital size should address much of the bias between American College of Surgeons
levels.
Statistical Analysis
Multivariate linear regression was used to test the differences in outcome
measures between subgroups after controlling for hospital factors. This was followed by
Tukey’s post hoc pairwise comparisons to test the significance of individual comparisons
between the four subpopulations.
All statistical analyses were performed using Stata® Version 13.0 (StataCorp, LP,
College Station, TX, USA). All statistical tests were two-tailed, and the level of
significance was set at α = 0.05. All analyses were adjusted for clustering by institution.
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Results
Demographics, Description of Study Population
A total of 58,977 patients met inclusion criteria. Of those, 35,119 patients had hip
fractures, 15,506 had nonoperative pelvic fractures, 7670 had acetabulum fractures, and
682 had operative pelvic fractures. Gender, age, Charlson Comorbidity Index, and Injury
Severity Score varied predictably between groups (Table 1). Of note, 6,180 hip fracture
patients (17.6% of all hip fractures) and 307 acetabular fracture patients (4.0% of all
acetabular fractures) were treated with arthroplasty surgery (total hip arthroplasty or
hemiarthroplasty).
Inpatient length of stay
Patients with operative pelvic fractures had the longest mean length of stay at 15.2
days (SD: 13.6 days; Figure 1). Mean length of stay for hip fracture patients was 6.6 days
(SD: 5.1 days), and this difference from operative pelvic fracture patients was statistically
significant after controlling for patient and hospital factors (difference: 7.7 days [95%
confidence interval: 7.0 to 8.4]; P < 0.001; Table 2). Non-operative pelvic fracture
patients had a mean length of stay of 6.5 days (SD: 8.2 days), and this difference from
operative pelvic fracture patients was statistically significant after controlling for patient
and hospital factors (difference: 8.0 days [95% confidence interval: 7.3 to 8.6]; P <
0.001). Acetabulum fracture patients had a mean length of stay of 8.7 days (SD: 9.5
days), and this difference from operative pelvic fracture patients was statistically
significant after controlling for patient and hospital factors (difference: 6.0 days [95%
confidence interval: 5.4 to 6.8]; P < 0.001).
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Table 1. Patient summary statistics
Patient factors

Hip fracture (n =
35,119)

Nonoperative
pelvic fracture (n =
15,506)

Acetabulum
fracture (n = 7670)

Operative pelvic
fracture (n = 682)

Gender
Female
Male

24,046
11,073

Age (years)
65-69
70-74
75-79
80-84
85+

(mean = 80)
3702
10%
4573
13%
6472
18%
9670
28%
10,702
30%

(mean = 79)
2002
13%
2105
14%
2773
18%
4172
27%
4454
29%

(mean = 77)
1804
24%
1437
19%
1352
18%
1626
21%
1451
19%

(mean = 73)
272
40%
150
22%
124
18%
84
12%
52
8%

Charlson
Comorbidity Index
3
4
5
6+

(mean = 5)
2219
6%
16,579
47%
9265
26%
7056
20%

(mean = 5)
1553
10%
8155
53%
3524
23%
2274
15%

(mean = 4)
1304
17%
3498
46%
1739
23%
1129
15%

(mean = 4)
223
33%
303
44%
101
15%
55
8%

Injury Severity
Score
0-9
10-14
15-19
20+

(mean = 10)
29,769
85%
3778
11%
637
2%
935
3%

(mean = 11)
10,052
65%
1996
13%
952
6%
2506
16%

(mean = 12)
4445
58%
1099
14%
636
8%
1490
19%

(mean = 20)
133
20%
125
18%
117
17%
307
45%

68%
32%

11,685
3821

Note: Underline indicates median values.
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75%
25%

3377
4293

44%
56%

252
430

37%
63%

Figure 1: Mean length of stay, inpatient care unit (ICU) stay, and mechanical ventilation time vary
between patients in each subgroup of DRG 536. Error bars represent standard error of the mean.

ICU stay
Patients with operative pelvic fractures had the longest mean ICU stay at 7.4 days
(SD: 10.5 days; Figure 1). Mean ICU stay for hip fracture patients was 0.7 days (SD: 2.7
days), and this difference from operative pelvic fracture patients was statistically
significant after controlling for patient and hospital factors (difference: 6.3 days [95%
confidence interval: 5.9 to 6.7]; P < 0.001; Table 3). Non-operative pelvic fracture
patients had a mean ICU stay of 1.6 days (SD: 4.7 days), and this difference from
operative pelvic fracture patients was statistically significant after controlling for patient
and hospital factors (difference: 5.4 days [95% confidence interval: 5.0 to 5.8]; P <
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0.001). Acetabulum fracture patients had a mean ICU stay of 2.8 days (SD: 6.4 days), and
this difference from operative pelvic fracture patients was statistically significant after
controlling for patient and hospital factors (difference: 4.3 days [95% confidence interval:
3.9 to 4.8]; P < 0.001).
Ventilator Time
Patients with operative pelvic fractures had the longest mean ventilator time at 4.5
days (SD: 9.7 days; Figure 1). Mean ventilator time for hip fracture patients was 0.2 days
(SD: 1.9 days), and this difference from operative pelvic fracture patients was statistically
significant after controlling for patient and hospital factors (difference: 3.9 days [95%
confidence interval: 3.6 to 4.2]; P < 0.001; Table 4). Non-operative pelvic fracture
patients had a mean ventilator time of 0.8 days (SD: 3.9 days), and this difference from
operative pelvic fracture patients was statistically significant after controlling for patient
and hospital factors (difference: 3.4 days [95% confidence interval: 3.1 to 3.7]; P <
0.001). Acetabulum fracture patients had a mean ventilator time of 1.5 days (SD: 5.1
days), and this difference from operative pelvic fracture patients was statistically
significant after controlling for patient and hospital factors (difference: 2.8 days [95%
confidence interval: 2.5 to 3.2]; P < 0.001).
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Table 2. Multivariate analysis of length of stay
Outcome: inpatient length of
stay
Subpopulations of DRG 536

Mean length of
stay, in days
(standard
deviation)

Difference from
operative pelvic
fractures, in days
(95% confidence
interval)

Hip fracture
Non-operative pelvic fracture
Acetabulum fracture
Operative pelvic fracture

6.6 (5.1)
6.5 (8.2)
8.7 (9.5)
15.2 (13.6)

7.7 (7.0-8.4)
8.0 (7.3-8.6)
6.0 (5.4-6.8)
Reference
Regression
coefficient, in days
(95% confidence
interval)

Patient and hospital factors
(controlled for in multivariate
analysis)
Charlson Comorbidity Index
3
4
5
6+

Multivariate
P-value

< 0.001
< 0.001
< 0.001
-

Multivariate
P-value

Reference
-0.5 (-0.7 to -0.3)
-0.1 (-0.4 to 0.1)
0.4 (0.2-0.6)

< 0.001
0.190
0.001

Hospital teaching status
Nonteaching
University
Community

Reference
1.4 (1.3-1.6)
0.4 (0.2-0.5)

< 0.001
< 0.001

Hospital size (beds)
≤ 200
201-400
401-600
> 600

Reference
0.5 (0.3-0.7)
1.0 (0.8-1.2)
1.4 (1.2-1.7)

< 0.001
< 0.001
< 0.001

Geographic region
Northeast
Midwest
South
West

Reference
0.39 (0.2-0.6)
0.49 (0.4-0.6)
0.21 (0.0-0.4)

< 0.001
< 0.001
0.016
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Table 3. Multivariate analysis of ICU length of stay
Outcome: intensive care unit
days
Subpopulations of DRG 536

Mean intensive
care unit stay, in
days (standard
deviation)

Difference from
operative pelvic
fractures, in days
(95% confidence
interval)

Hip fracture
Non-operative pelvic fracture
Acetabulum fracture
Operative pelvic fracture

0.7 (2.7)
1.6 (4.7)
2.8 (6.4)
7.4 (10.5)

6.3 (5.9-6.7)
5.4 (5.0-5.8)
4.3 (3.9-4.8)
Reference
Regression
coefficient, in days
(95% confidence
interval)

Patient and hospital factors
(controlled for in multivariate
analysis)
Charlson Comorbidity Index
3
4
5
6+

Multivariate
P-value

< 0.001
< 0.001
< 0.001
-

Multivariate
P-value

Reference
-0.4 (-0.6 to -0.3)
-0.4 (-0.5 to -0.2)
-0.3 (-0.4 to -0.3)

< 0.001
< 0.001
< 0.001

Hospital teaching status
Nonteaching
University
Community

Reference
0.9 (0.8-1.0)
0.1 (0.0-0.2)

< 0.001
0.012

Hospital size (beds)
≤ 200
201-400
401-600
> 600

Reference
0.2 (0.0-0.3)
0.4 (0.2-0.5)
0.7 (0.5-0.8)

0.005
< 0.001
< 0.001

Geographic region
Northeast
Midwest
South
West

Reference
-0.3 (-0.4 to -0.2)
0.1 (0.02-0.2)
0.3 (0.2-0.4)

< 0.001
0.017
< 0.001

ICU = intensive care unit.
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Table 4. Multivariate analysis of ventilator days
Outcome: mechanical
ventilation days
Subpopulations of DRG 536

Mean mechanical
ventilation time, in
days (standard
deviation)

Difference from
operative pelvic
fractures, in days
(95% confidence
interval)

Hip fracture
Non-operative pelvic fracture
Acetabulum fracture
Operative pelvic fracture

0.2 (1.9)
0.8 (3.9)
1.5 (5.1)
4.5 (9.7)

3.9 (3.6-4.2)
3.4 (3.1-3.7)
2.8 (2.5-3.2)
Reference
Regression
coefficient, in days
(95% confidence
interval)

Patient and hospital factors
(controlled for in multivariate
analysis)
Charlson Comorbidity Index
3
4
5
6+

Multivariate
P-value

< 0.001
< 0.001
< 0.001
-

Multivariate
P-value

Reference
-0.3 (-0.4 to -0.2)
-0.3 (-0.4 to -0.2)
-0.3 (-0.4 to -0.2)

< 0.001
< 0.001
< 0.001

Reference
0.6 (0.5-0.7)
0.1 (0.1-0.2)

< 0.001
< 0.001

Hospital size (beds)
≤ 200
201-400
401-600
> 600

Reference
0.0 (0.0 to 0.1)
0.2 (0.0-0.2)
0.4 (0.2-0.5)

0.346
0.004
< 0.001

Geographic region
Northeast
Midwest
South
West

Reference
-0.2 (-0.2 to -0.1)
0.1 (0.0-0.2)
0.1 (0.1-0.2)

< 0.001
0.002
0.001

Hospital teaching status
Nonteaching
University
Community
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Discussion
The current Medicare Acute Inpatient Prospective Payment System determines
reimbursement for inpatient admissions by categorizing patients into 746 MS-DRGs that
are annually revised. Inpatient admissions under the same DRG are reimbursed with the
same prospective, “bundled” payment, regardless of actual hospital costs. Currently,
DRG 536 (fractures of the hip and pelvis) includes a broad spectrum of orthopaedic
injuries, from low-energy fragility fractures of the hip to high-energy acetabulum and
pelvic fractures. With the absolute incidence of elderly fractures expected to increase
dramatically due to the growing elderly population 73, 74 and the high costs of managing
these injuries,, any substantial variation in costs may result in over- or underreimbursement to certain hospitals, based on their percentage of high-energy versus lowenergy elderly fractures treated. Excess financial strain on these hospitals treating highenergy trauma patients may even result trauma center closures or shifts away from
managing high-energy trauma, resulting in reduced access for these patients. Similar
discrepancies between hospital costs and Medicare reimbursements have also been seen
within other Medicare DRGs in the past 76, 77. The results of the current study
demonstrate that, even after controlling for patient and hospital factors, there were
important differences in various measures of resource utilization between the four
subgroups of Medicare DRG 536. These differences indicate that hospitals are currently
receiving under- or over-reimbursement for certain subgroups, depending on their
baseline reimbursement for DRG 536. In particular, these increases in resource utilization
were most striking for patients with the fractures more likely to be associated with higher
energy mechanisms: operative pelvic fractures and acetabulum fractures.
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The primary limitation of this study stems from this exclusion of true cost figures.
Standard methods of healthcare cost estimation have important limitations. Cost
measurement using charges or cost-to-charge ratios estimates only total costs, and not the
marginal costs of services, and ignores cost shifting that occurs regularly in hospital
accounting 79, 80. However, the current study uses various measures of resource utilization
as a proxy for costs. With the estimated costs of an inpatient day at USD 1236, an ICU
day at USD 2278 to USD 5973, and a day on mechanical ventilation at USD 10,299 81, 82,
the results presented in the current study do represent significant differences between
subpopulations of DRG 536. An additional limitation of this study is the inability to
identify patients with major complications or comorbidities (MCCs), who might be
classified into DRG 535 (fractures of the hip or pelvis with MCCs) based on the ICD-9
diagnosis data given in the National Trauma Data Bank. The authors acknowledge that
inability to identify patients with major complications or comorbidities may result in
overestimation of resource utilization for the subgroups of DRG 536 that are associated
with higher rates of major comorbidities and complications. Higher-energy fractures,
associated with greater total burden of bodily injury, may very likely also be associated
with greater inpatient complications due to more complex inpatient course and longer
length of stay. In addition, lower energy fractures associated with osteoporosis may also
be associated with higher rates of comorbidities and complications, due to poorer overall
health status. However, by controlling for Charlson Comorbidity Index, the current study
shows differences in resource utilization that are independent of age and comorbidities.
These differences likely indicate disparities in resource utilization for patients in both
DRG 535 and DRG 536. Nevertheless, further study using true cost figures and DGR
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classifications at a single-institution is warranted to estimate the actual financial burden
caused by the large spectrum of patients included in DRG 536.
Another limitation of the current study results from the inherent biases associated
with using a national dataset such as the National Trauma Data Bank. While the NTDB
includes data from over 900 trauma centers, this data is self-reported by hospitals and
accuracy is dependent on the accuracy of data submitted from individual hospitals.
Hospital may submit incomplete datasets resulting in over- or under representation of
certain fracture types. Nevertheless, the large overall size of the dataset allowed
statistically significant differences to be identified, despite large disparities in sample size
between subpopulations (there were far more hip fractures than operative pelvic
fractures). Selection bias is also possible as the dataset, while including data from over
900 U.S. trauma centers, is not necessarily nationally representative. There may certainly
be biases toward level I and II trauma centers which see greater numbers of high-energy
trauma patients. Nevertheless, the aim of the current study was not to measure the relative
incidences of the different subpopulations included in MS-DRG 536, but rather to
compare how resource utilization varies between patients with these different
subpopulations. By controlling for hospital factors, such as hospital size, teaching status,
and geographic region, the current study attempts to control for local variations in
resource utilization and isolate the differences in utilization attributable to the various
injury types. Another type of bias that may be present is transfer bias, as a percentage of
patients in the National Trauma Data Bank have incomplete data regarding inpatient
length of stay, ICU stay, or ventilator time. These patients were excluded from the
analysis. Of a total of 69,055 patients in MS-DRG 536 and aged 65 or older in the

64

National Trauma Data Bank, 10,078 patients were dropped due to incomplete data in
regards to inpatient length of stay (n = 478), ICU stay (n = 7,484), or ventilator time (n =
8,534) resulting in the 58,977 patients ultimately analyzed. It may be that patients with
more severe acute injuries and complicated inpatient courses represent a higher
percentage of these patients with incomplete data, biasing the current study results.
However, in a post hoc analysis the mean Injury Severity Score for these dropped
patients was 9.9, compared to 10.6 in the analyzed patients. This difference of 0.7 in
Injury Severity Score, while statistically significant (P < 000.1) due to large sample size,
was not clinically significant.
Previous work in the field of orthopaedics showed similar differences in inpatient
costs and resource utilization between primary and revision total joint arthroplasty 77, 78,
at the time both grouped under Medicare DRG 209 (lower extremity arthroplasty). An
initial multicenter cohort study demonstrated differences in operative time, use of
allograft, length of stay, and costs, between almost 8,000 patients undergoing either
primary or revision hip and knee arthroplasty 78. A subsequent study at a single institution
demonstrated mean differences in hospital costs of over $7,000 per patient between
revision and primary arthroplasty patients 77. This work ultimately supported efforts by
the American Association of Orthopaedic Surgeons, the American Association of Hip
and Knee Surgeons, and the Hip Society to propose modification of the DRG to the
Centers for Medicare & Medicaid Services (CMS). This was ultimately accepted in 2005
with creation of two new DRGs: DRG 544 (primary hip and knee replacement) and DRG
545 (revision hip and knee replacement) 76. Similar efforts with DRG 536 should be
pursued, next with analysis of true cost figures. This should be conducted within a single
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institution because comparing hospital costs between multiple institutions becomes
complicated due to varying cost accounting practices. In addition, further investigation of
other MS-DRGs that include a broad spectrum of orthopaedic patients may be warranted.
One such example is DRG 563, which includes all fractures, sprains, strains, and
dislocations, excluding those of the femur, hip, and pelvis.
A secondary finding of the current study was the associations of patient and
hospital factors with resource utilization. As expected, increased Charleston Comorbidity
Index is associated with increased costs, likely due to increased resources necessary to
treat patients with worse overall health status. In addition, it was found that larger
hospitals and University hospitals were associated with increased utilization. This would
be expected as more critically injured patients are often seen in larger, universityassociated trauma centers 83. Previous studies have demonstrated worse outcomes for hip
fractures managed at teaching hospitals compared to non-teaching hospitals, suggesting
more severely injured patients. In addition, a previous study specifically demonstrated
increased resource utilization in university hospitals compared to community teaching
hospitals for tPA treated stroke patients 84. The geographic differences observed have not
been previously described but likely results from regional variations in hospital practices
and physician customs for inpatient discharge and ICU transfer.
Now may be an opportune time for CMS to reevaluate classification of DRG 536
because the Medicare DRG system may soon see more-expanded use. As part of the
Patient Protection and Affordable Care Act (PPACA), the CMS Bundled Payments for
Care Improvement Initiative will test new bundled payment delivery models aimed at
reducing costs and improving quality of care 85. Three of the four proposed models, all
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currently being tested, expand bundling of payments to include services outside of
inpatient hospital care including physician services and postacute care services. All four
models use the current MS-DRG system to categorize patients. The American
Association of Hip and Knee Surgeons has already created a Bundled Payment Task
Force to identify issues in the system specific to hip and knee surgeons and to aid in the
eventual transition 86, 87. In addition, many private health plans, which cover patients of
all ages, use a MS-DRG based model for reimbursement. However, as low-energy
fragility fractures are less common in younger patients we would expect less variation in
resource utilization between patients with hip or pelvis fractures, which would all more
likely result from higher energy mechanisms. Similar measures should be taken
throughout the field of orthopaedic surgery, including in the field of orthopaedic trauma,
which sees over two million elderly patients with fragility fractures annually 88.
In conclusion, the current study demonstrates considerable variation in resource
utilization for hospital admissions due to hip or pelvis fractures, which are all reimbursed
equally under DRG 536. With the current multitiered US trauma system, it is very likely
that some trauma centers treat a higher proportion of the more the resource-intensive
injuries, resulting in higher costs and lower financial margins. Appropriate
reimbursement of hospital services is essential for maintaining patient access to inpatient
care in the currently shifting US healthcare landscape. Therefore, creating a separate MSDRG for operative pelvic fractures and acetabulum fractures would likely help reduce
this financial strain. Further comparison of true cost figures at a single institution may be
a suitable next step to demonstrate clear financial benefits of regulatory changes. Indeed,
just as new healthcare standards and quality benchmarks are currently being developed in
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the field of orthopaedics to meet PPACA guidelines, the classification of Medicare DRGs
for orthopaedic diagnoses such as hip and pelvic fractures also presently warrant
reevaluation.
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Conclusion of Thesis
The preceding three studies illustrate the utility of “big data” for studying
orthopaedic trauma patients, a unique patient population that may require special
considerations when designing clinical analyses. In Section I, we demonstrated that not
all national databases capture the typical high-energy fracture populations well, including
the commonly used NSQIP database that primarily includes elderly fragility type fracture
patients. As a result, fully understanding the populations contained in various national
databases is critical before designing or evaluating database research. Trauma specific
databases such as NTDB are best suited to study high-energy trauma patients, however
they are not as nationally representative of fracture patients as databases with systematic
sampling techniques, such as NIS.
In Section II the NTDB was utilized to identify a number of risk factors
associated with delayed hip fracture surgery, including coagulopathy, congestive heart
failure, and arthroplasty surgery. These findings were then used to conduct a more in
depth analysis using a local cohort of hip fracture patients. It was found that total hip
arthroplasty was associated with the greatest delays of over 24 hours, while warfarin
anticoagulation, other chronic anticoagulation, and recent CHF exacerbations were
additional risk factors. The importance of appropriate surgeon staffing and medical comanagement of patients were highlighted as possible areas for improvement with
increasing evidence and guidance for earlier surgical intervention after hip fractures.
Finally in Section III the NTDB was again used to demonstrate that management
of both operative pelvic fractures and acetabulum fractures require substantially greater
hospital resource utilization, compared to hip fractures or non-operative pelvic fractures.
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This finding is interesting as hospitals are reimbursed equally for treatment of each of
these types of fractures under Medicare DRG 536. For hospitals that manage a relatively
greater number of higher energy injuries, such as acetabulum fractures or operative pelvic
fractures, financial returns per patient would be lower relative to other hospitals. As a
result, refinement of this Medicare DRG to separate these higher cost injuries was
recommended, just as has been done for primary and revision arthroplasty patients, who
were also previously grouped into the same Medicare DRG.
In conclusion, thoughtfully designed clinical studies using “big data” will
continue to be used to study orthopaedic trauma populations, and these studies will be
both hypothesis-finding and hypothesis-testing. While there remain limitations to national
databases that are currently in use, many of these limitations can be addressed with
thoughtful design of orthopaedic trauma-focused databases in the future. A hip fracturespecific NSQIP dataset, currently in data collection phase, is a first step, while
development of robust institutional orthopaedic trauma registries at busy trauma centers,
which may even leverage electronic health records for automated data collection, may
provide a wealth of clinical data for future clinical study.
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Appendices
Appendix 1: Data elements used to identify comorbidities in NIS, NSQIP, and NTDB
Comorbidity
Alcoholism

NIS data element
“cm_alcohol”
(Alcohol abuse)

Bleeding
disorder
Diabetes
mellitus

“cm_coag”
(Coagulopathy)
“cm_dm”
(Diabetes,
uncomplicated)
“cm_dmcx”
(Diabetes with
chronic
complications)
“cm_mets”
(Metastatic cancer)
“cm_htn_c”
(Hypertension,
uncomplicated and
complicated)
“cm_obese”
(Obesity)

Disseminated
cancer
Hypertension

Obesity

NSQIP data element
“etoh” (EtOH >
drinks/day in 2 wks
before admission)
“bleeddis” (Bleeding
disorders)
“diabetes" (Diabetes
mellitus with oral
agents or insulin)

NTDB data element
“comorkey” = 2
(Alcoholism)

“discancr”
(Disseminated cacner)
“hypermed”
(Hypertension requiring
medication)

“ comorkey” = 12
(Disseminated cancer)
“comorkey” = 19
(Hypertension
requiring medication)

“comorkey" = 4
(Bleeding disorder)
“comorkey” = 11
(Diabetes mellitus)

“height” (Height)
“comorkey” = 22
(Obesity)
“weight” (Weight)†
Current smoker
ICD-9 diagnosis
“smoke” (Current
“comorkey" = 8
305.1 (Tobacco Use
smoker within one
(Current smoker)
Disorder)
year)
†
In NSQIP obesity was defined as 703*(weight/(height*height)) ≥ 30 [BMI ≥ 30]
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Appendix 2: Data elements used to identify inpatient adverse events in NIS, NSQIP, and
NTDB
Adverse event

NIS data element or ICD- NSQIP data element
9 diagnosis code
Acute kidney
• 584.X (Acute kidney
• “noprenafl” (Acute renal
injury
injury)
failure, postoperative)
• “nreninsf” (Progressive renal
insufficiency, postoperative)
Cardiac arrest
• 427.41 (Ventricular
• “ncdarrest” (Cardiac arrest
fibrillation)
requiring cardiopulmonary
resuscitation, postoperative)
• 427.5 (Cardiac arrest)
Cerebrovascular • 430 (Subarachnoid
• “ncnscva” (Stroke/CVA,
accident (CVA)
hemorrhage)
postoperative)
• 431 (Intracerebral
hemorrhage)
• 433.X1 (Precerebral
artery occlusion and
stenosis with cerebral
infarction)
• 434.X1 (Cerebral artery
occlusion with cerebral
infarction)
• 997.02 (Iatrogenic
cerebrovascular infarction
or hemorrhage)
Death
• “died” (Death)
• “dopertod” ≤ “doptodis”
(Date of death ≤ Date of
discharge)

NTDB data element
• “complkey” = 4 (Acute
kidney injury)

• “complkey” = 8
(Cardiac arrest with
CPR)
• “complkey” = 22
(Stroke / CVA)

Deep vein
thrombosis
(DVT)/
Pulmonary
embolism

• 415.1 (Pulmonary
embolism)
• 452.X-454.X, 453.82,
453.84, 453.85, 453.86
(Acute embolism and
thrombosis of deep vein)

• “nothdvt” (DVT, with or
without inflammation,
postoperative)
• “npulembol” (Pulmonary
embolism, postoperative)

• “hospdisp” = “Expired”
(Death)
• “eddisp” = “Died”
(Death)
• “complkey” = 14
(DVT/
thrombophlebitis)
• “complkey” = 21
(Pulmonary embolism)

Myocardial
infarction
Pneumonia

• 410.X (Acute myocardial
infarction)
• 480-486
• (Pneumonia/
Bronchopneumonia)
• 998.5X (Postoperative
infection, not elsewhere
classified)
• 998.67 (Infection and
inflammatory reaction
due to other internal
orthopedic device,
implant, or graft)

• “ncdmi” (Myocardial
infarction, postoperative)
• “noupneumo” (Pneumonia,
postoperative)

• “complkey” = 18
(Myocardial infarction)
• “complkey” = 20
(Pneumonia)

• “nsupinfec” (Superficial
SSI, postoperative)
• “nwndinfd” (Deep SSI,
postoperative)

• “complkey” = 12 (Deep
SSI)
• “complkey” = 19
(Organ/space SSI)
• “complkey” = 23
(Superficial SSI)

• 599.0 (Urinary tract
infection)

• “nurninfec” (Urinary tract
infection, postoperative)

Surgical site
infection (SSI)

Urinary tract
infection

• “norgspcssi” (Organ/space
SSI, postoperative)
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• “complkey” = 27
(Urinary tract infection)
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